Essential medicines need caps for affordability, but manufacturers also need incentives and flexibility to avoid shortages. A hybrid approach (caps + subsidies + import competition) balances affordability and supply.
Here are the top political news stories for today.
Be the first to reply to this answer.
Join in on more popular conversations.